MarketInOut Stock Screener Log In | Sign Up
 

PROCEBioRobotics Corp

NASDAQ • Healthcare • Medical Devices • Quote as of 10/23/2026
PROCEBioRobotics Corp stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization1,138.03 mln
Float54.63 mln
Earnings Date11/04/2026

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-2.47
Borderline

1-Year Forecast

22.25
Modest upside

Relative Strength

93 / 100
Top performer

Debt / Equity

0.23
Very low leverage

Pre-Tax Margin

-32%
Deeply loss-making

Business Description

PROCEPT BioRobotics designs and sells robotic surgical systems that help treat men with an enlarged prostate, a condition that can cause difficulty urinating. Its core products use water-based technology guided by real-time imaging to perform precise, minimally invasive procedures. Founded in 2007 and based in San Jose, California, the company serves patients and healthcare providers across the United States and around the world.

Key Fundamentals

EPS-1.94
ROE-30.16
RPS5.99
ROIC-53.69
ROA-21.96
Interest Cover-32.89
EBITDA, mln-98.99
EV / EBITDA-8.98
EV / EBIT-8.38
Revenue, mln337
EV / Revenue2.64

Quote Details

Last 19.96
Change -0.07 (-0.35%)
Open 19.90
Volume 773,695
Turnover 15,442,951
Average Volume 1,353,095

Financial Ratios

Pre-Tax Profit Margin-32
Leverage Ratio1.41
Current Ratio6.54
Price / Book3.07
Price / Tangible Book3.07
Debt / Equity0.23
Price / Sales3.05

Financial Strength

Altman Z-Score3.27
Piotroski F-Score 4 / 9
Beneish M-Score-2.47
1-Year Target Price22.25
Short Ratio5.41
Short % of Float13.35

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 13.6% 96 / 100   
1 Month 14.06% 95 / 100   
2 Months 3.85% 80 / 100   
6 Months -18.06% 27 / 100   
1 Year -43.13% 20 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog